Press coverage about Novadaq Technologies (NASDAQ:NVDQ) (TSE:NDQ) has trended somewhat positive on Monday, according to Accern Sentiment. The research group ranks the sentiment of media coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Novadaq Technologies earned a daily sentiment score of 0.14 on Accern’s scale. Accern also assigned news stories about the medical research company an impact score of 46.2215599137449 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

These are some of the media headlines that may have impacted Accern Sentiment Analysis’s analysis:

Shares of Novadaq Technologies (NASDAQ NVDQ) traded down 0.09% during trading on Monday, reaching $11.68. 488,257 shares of the company’s stock were exchanged. The stock has a 50-day moving average price of $11.09 and a 200 day moving average price of $8.17. Novadaq Technologies has a 12-month low of $5.84 and a 12-month high of $12.74. The company’s market capitalization is $675.13 million.

NVDQ has been the subject of a number of recent research reports. Stifel Nicolaus reiterated a “buy” rating and issued a $10.00 target price on shares of Novadaq Technologies in a report on Friday, June 2nd. Scotiabank reiterated an “outperform” rating and issued a $18.00 target price on shares of Novadaq Technologies in a report on Wednesday, April 26th. Zacks Investment Research upgraded shares of Novadaq Technologies from a “sell” rating to a “hold” rating in a report on Tuesday, May 9th. Canaccord Genuity downgraded shares of Novadaq Technologies from a “buy” rating to a “hold” rating and set a $11.75 target price for the company. in a report on Monday, July 10th. Finally, Northland Securities reiterated a “hold” rating and issued a $11.75 target price on shares of Novadaq Technologies in a report on Monday, June 19th. One analyst has rated the stock with a sell rating, twelve have given a hold rating and two have assigned a buy rating to the company’s stock. Novadaq Technologies presently has a consensus rating of “Hold” and a consensus price target of $11.86.

TRADEMARK VIOLATION NOTICE: This news story was published by Daily Political and is the sole property of of Daily Political. If you are accessing this news story on another site, it was copied illegally and reposted in violation of United States and international copyright and trademark law. The correct version of this news story can be read at https://www.dailypolitical.com/2017/08/07/somewhat-positive-press-coverage-somewhat-unlikely-to-affect-novadaq-technologies-nvdq-stock-price.html.

About Novadaq Technologies

NOVADAQ Technologies Inc is a medical device company. The Company primarily develops, manufactures and markets real-time fluorescence imaging products that are designed for use by surgeons in the operating room and other clinical settings where open and minimally invasive surgery or interventional procedures are performed.

Insider Buying and Selling by Quarter for Novadaq Technologies (NASDAQ:NVDQ)

Receive News & Ratings for Novadaq Technologies Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novadaq Technologies Inc and related companies with MarketBeat.com's FREE daily email newsletter.